Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06972875 · ClinicalTrials.gov registry record · Phase 2

Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer

A Phase 2 study of Androgen Deprivation Therapy and Prostate CA, sponsored by University of Vermont.

Recruiting
Registry status
Phase 2
Development phase
32
Enrollment target
1
Study location

NCT06972875 is a Phase 2 study of Androgen Deprivation Therapy and Prostate CA that is actively recruiting participants, run by University of Vermont. The registered enrollment target is 32 participants, below the 46-participant average among 5 other Androgen Deprivation Therapy trials with a reported enrollment target (30% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06972875, a Phase 2 study of Androgen Deprivation Therapy and Prostate CA, is actively recruiting participants, sponsored by University of Vermont.

RECRUITING
Registry status
Phase 2
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

This study is for men with prostate cancer who are experiencing hot flashes due to treatments that lower testosterone. Hot flashes can affect your quality of life and make it harder for patients to continue their treatment, so researchers want to find a better way to manage them. The study is testing a drug called fezolinetant, which might help reduce hot flashes without using hormones. Fezolinetant is a drug that is currently approved for the treatment of hot flashes in menopausal women.

Conditions Studied

Androgen Deprivation Therapy Prostate CA

Interventions

  • DRUG Fezolinetant

Study Locations (1)

Vermont

  • University of Vermont Medical Center - Burlington

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2025-12-18
Est. Completion 2027-02
Phase Phase 2

Sponsor

University of Vermont

162 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06972875

The ClinicalTrials.gov registry entry for NCT06972875 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 46-participant average among 5 other Androgen Deprivation Therapy trials with a reported enrollment target (30% lower). The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Androgen Deprivation Therapy appearing as the primary indexed condition, and to 1 intervention - of which Fezolinetant is the first listed.

NCT06972875 reports 1 study location spanning 1 distinct geographic area - top geographies include Vermont.

Frequently Asked Questions

What is clinical trial NCT06972875 about?

NCT06972875 is a clinical study titled "Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer". This study is for men with prostate cancer who are experiencing hot flashes due to treatments that lower testosterone. Hot flashes can affect your quality of life and make it harder for patients to continue their treatment, so researchers want to find a better way to manage them. The study is testin...

What is the current status of trial NCT06972875?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2025-12-18. Estimated completion is 2027-02.

What conditions does trial NCT06972875 study?

This clinical trial studies the following conditions: Androgen Deprivation Therapy, Prostate CA.

What interventions are being tested in trial NCT06972875?

The interventions under investigation include: Fezolinetant (DRUG).

Who is sponsoring clinical trial NCT06972875?

This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06972875 being conducted?

This trial has 1 study location across Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Androgen Deprivation Therapy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Androgen Deprivation Therapy

All registered trials for this condition

Prostate CA

All registered trials for this condition

Vermont

All trials with a study site in Vermont

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.